Healthcare provider profile · identity verified

Lori Weide, MD

Family Practice · CANTON, MI · NPI 1659344562

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	480	137
Lisinopril	Lisinopril	392	115
Levothyroxine Sodium	Levothyroxine Sodium	335	90
Amlodipine Besylate	Amlodipine Besylate	275	89
Omeprazole	Omeprazole	255	84
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	246	34
Alprazolam	Alprazolam	243	43
Losartan Potassium	Losartan Potassium	211	62
Hydrochlorothiazide	Hydrochlorothiazide	197	64
Simvastatin	Simvastatin	162	44
Metoprolol Succinate	Metoprolol Succinate	160	45
Rosuvastatin Calcium	Rosuvastatin Calcium	151	47
Metformin Hcl	Metformin Hcl	141	47
Gabapentin	Gabapentin	137	34
Sertraline Hcl	Sertraline Hcl	125	35
Metoprolol Tartrate	Metoprolol Tartrate	113	31
Fluticasone Propionate	Fluticasone Propionate	111	41
Pantoprazole Sodium	Pantoprazole Sodium	109	31
Zolpidem Tartrate	Zolpidem Tartrate	107	19
Lorazepam	Lorazepam	91	20
Ibuprofen	Ibuprofen	83	36
Metformin Hcl Er	Metformin Hcl	82	27
Albuterol Sulfate Hfa	Albuterol Sulfate	80	40
Meloxicam	Meloxicam	77	24
Trazodone Hcl	Trazodone Hcl	74	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	16
Tramadol Hcl	Tramadol Hcl	66	19
Eliquis	Apixaban	65	20
Atenolol	Atenolol	62	18
Glipizide Er	Glipizide	61	18
Citalopram Hbr	Citalopram Hydrobromide	60	15
Januvia	Sitagliptin Phosphate	57	15
Oxycodone Hcl	Oxycodone Hcl	57	suppressed
Alendronate Sodium	Alendronate Sodium	54	16
Clonazepam	Clonazepam	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	52	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	51	suppressed
Jardiance	Empagliflozin	51	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	15
Allopurinol	Allopurinol	45	15
Montelukast Sodium	Montelukast Sodium	43	14
Potassium Chloride	Potassium Chloride	43	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Pravastatin Sodium	Pravastatin Sodium	40	12
Ventolin Hfa	Albuterol Sulfate	40	11
Furosemide	Furosemide	39	14
Ropinirole Hcl	Ropinirole Hcl	39	13
Buspirone Hcl	Buspirone Hcl	36	11
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Famotidine	Famotidine	36	13
Prednisone	Prednisone	36	19
Chlorthalidone	Chlorthalidone	35	13
Donepezil Hcl	Donepezil Hcl	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Paroxetine Hcl	Paroxetine Hcl	35	11
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	11
Clopidogrel	Clopidogrel Bisulfate	34	12
Tamsulosin Hcl	Tamsulosin Hcl	34	12
Bupropion Xl	Bupropion Hcl	33	suppressed
Baclofen	Baclofen	32	16
Carvedilol	Carvedilol	32	11
Glipizide	Glipizide	32	11
Warfarin Sodium	Warfarin Sodium	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Diazepam	Diazepam	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Rybelsus	Semaglutide	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	12
Naproxen	Naproxen	28	17
Xarelto	Rivaroxaban	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	12
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Ozempic	Semaglutide	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Finasteride	Finasteride	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Aripiprazole	Aripiprazole	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Lactulose	Lactulose	20	suppressed
Topiramate	Topiramate	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Mounjaro	Tirzepatide	19	suppressed
Amoxicillin	Amoxicillin	18	15
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Cephalexin	Cephalexin	18	16
Epinephrine	Epinephrine	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Nystatin	Nystatin	18	12
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Azithromycin	Azithromycin	17	13
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Estradiol	Estradiol	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluconazole	Fluconazole	15	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Linzess	Linaclotide	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error